Compound E, chemically designated as 209986-17-4 (CAS), represents a significant investigation within the field of Alzheimer's disease research. This γ-secretase inhibitor was initially developed as a promising https://poppiejemr537229.blog-gold.com/57414488/γ-secretase-inhibitor-compound-e-209986-17-4